These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9815959)

  • 1. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
    Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
    Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
    Drew L; Groome N; Warr JR; Rumsby MG
    Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
    Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
    Basu A; Lazo JS
    Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
    Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
    Gschwend JE; Fair WR; Powell CT
    Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A; Akerman K; Heikkilä J
    J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
    Dale IL; Bradshaw TD; Gescher A; Pettit GR
    Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C; Gescher A; Bradshaw TD; Pettit GR
    Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
    Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
    Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness.
    Johnson MD; Torri JA; Lippman ME; Dickson RB
    Exp Cell Res; 1999 Feb; 247(1):105-13. PubMed ID: 10047452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells.
    Yang JM; Chin KV; Hait WN
    Cancer Res; 1996 Aug; 56(15):3490-4. PubMed ID: 8758935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL; May WS; Tyler PG; Hess AD
    J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
    Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
    Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A; Weixel K; Saijo N
    Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
    Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
    Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
    J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.